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1. Introduction
Clonidine was synthesized in 1962 as nasal decongestant, and marketed as antihypertensive
in 1972. Bloor and Flacke in 1982 [1] demonstrated in mongrel dogs that intravenous clonidine
5 and 20 µg/kg decreased halothane MAC by 42% and 48% respectively. Since then, clonidine
has been used by anaesthesiologists as an anaesthetic adjunct to provide increased perioper‐
ative cardiovascular and sympathoadrenal stability, to enhance general and regional anaes‐
thesia, as well as sedation and analgesia. [2, 3] In 1999, dexmedetomidine, a novel selective
and specific alpha2 agonist, was approved for postoperative sedation in intensive care patients,
and has also been investigated in general anaesthesia, regional anaesthesia and pain treatment.
Basic research in animals and clinical studies in humans performed with epidural clonidine
have shown its analgesic effects, with less side effects than any other neuroaxial anaesthesia
adjuvant. Similar results were also obtained with intrathecal injection of clonidine. Due to the
short duration of analgesic action by the latter route, the extradural administration is the most
studied. Epidural administration of clonidine has been widely utilized; indeed, the FDA has
only approved peridural use of clonidine infusion in chronic pain patients. There are many
publications with epidural clonidine for intraoperative surgical pain as an adjunct to general
anaesthesia and epidural anaesthesia, postoperative pain, pediatrics, and labour analgesia. It
has been used alone, or in combination with local anaesthetics, opioids, in bolus, or by
continuous infusion.
Intrathecal administration of clonidine is an interesting alternative route of administration. As
an alpha2 agonist, spinal injected clonidine prolongs sensory and motor block, increases
sedation and may potentiate hypotension and bradycardia. It has been used in high (> 150 µg),
low (< 150 µg) and small (< 75 µg) doses. High doses 150, 300 and 450 µg produce dose
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dependent analgesia, enhance spinal anaesthesia, with relative hemodynamic stability.
Furthermore, doses of 15 and 30 µg in addition to spinal local anaesthetics provide better
sensory and motor block compared to local anaesthetics alone. [4, 5]
The optimal dose of spinal clonidine remains unknown. For short ambulatory procedures 15
to 75 µg added to local anaesthetics enhance spinal anaesthesia without negative impact on
home discharge criteria. For short-stay or longer hospitalization surgeries, doses from 150 up
to 450 µg of clonidine as adjuvant for any local anaesthetics are safe, prolongs motor and
sensory block, and reduces the need of postoperative opioids.
This chapter updates current data on dose-response relationship of subarachnoid clonidine
when added as adjunct to spinal local anaesthetics and/or spinal opioids in different clinical
surgery scenarios, as well as for postoperative analgesia and labour pain.
2. Spinal additives
Spinal adjuvant drugs have been used since the beginning of subarachnoid anaesthesia.
Adrenaline, an alpha2 agonist, was the first drug used to enhance duration of spinal anaes‐
thesia, and morphine was the first opioid injected with eucaine in the lumbar spinal space to
relieve vertebral pain. [6] After the first article on spinal analgesia using opioids written by
Yaksh and Rudy in 1976, [7] the neuroaxial route to inject opioids as adjuvants drugs grew
logarithmically. Morphine, fentanyl, sufentanyl and many more agonist opioids have proven
their safety and efficacy to decrease the dose of local anaesthetics, to facilitate a faster recovery,
and effective postoperative analgesia. There are many receptors which modulates spinal pain
response; however, there are only few FDA approved drugs to be used via subarachnoid as
adjuvants or sole medications.
Many drugs have being injected into the spinal or peridural space in order to provide analgesia
and/or to enhance neuraxial anaesthesia. Nowadays, opioids are the more frequently used
spinal additives, but their side effects may limit its use; pruritus, urinary retention and late
respiratory depression. There are studies with intrathecal adjuvants that have not been
approved to be used in spinal anaesthesia: midazolam, ketamine, neostigmine, magnesium
sulphate, calcium channel blockers, nonsteroidal anti-inflammatory, dexmedetomidine,
tizanidine, etcetera.
3. Alpha2 adrenergic agonist drugs
Alpha2 agonist medications are used as adjuvants in anaesthesia and analgesia. They can be
prescribed orally, transdermally, intravenously, perineuraly, or through the neuroaxial route.
Beside analgesia and sedation, they decrease sympathetic tone and attenuate the stress
response to anaesthesia and surgery. Although adrenaline was the first alpha2 agonist used
intrathecally, it is no longer recommended. Nowadays, clonidine is the most used alpha2
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agonist in neuroaxial anaesthesia, even though dexmedetomidine has also recently been
studied for epidural and spinal anaesthesia adjuvant. Clonidine acts as a selective partial
agonist with a ratio of 200:1, whereas dexmedetomidine is highly selective with a ratio of
1600:1. Tizanidine, 5-bromo-N-[4, 5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine (UK-14,
304], and moxonidine are other alpha2 agonists with a potential neuroaxial use. [8, 9, 10, 11]
More than 90 patents have been deposited recently regarding different methods of alpha2
modulation (use of agonists or antagonists, nucleic acids and polypeptides) for diagnosis,
prognosis and treatment of disorders involving this receptors.
4. Clonidine
This prototypical alpha2 adrenergic receptor agonist was developed in the early 1960s. It is an
imidazoline derivative that exists as a mesomeric compound. It has a molecular weight of
266.56, chemical name is Benzenamine, 2, 6-dichloro-N-2-imidazolindinylidene monohydro‐
chloride and 2-[[2, 6-dichlorophenyl) imino] imidazolidine monohidrochloride. Figure 1
shows its structural formula (C9H9Cl2N3 HCl). Clonidine stimulates alpha2 adrenoreceptors
in the brain and spinal cord, resulting in reduction of sympathetic outflow from the central
nervous system and in decreased in peripheral resistance, renal vascular resistance, plasma
renin activity, heart rate, cardiac output, and blood pressure. Normal postural reflexes are
intact; therefore, orthostatic symptoms are mild and infrequent. Plasmatic level of clonidine
peaks in approximately 3 to 5 hours and the plasma half-life ranges from 12 to 16 hours. The
half-life increases up to 41 hours in patients with severe renal impairment. Following oral
administration, approximately 75% is bioavailable in men, about 40-60% of the absorbed dose
recovered unchanged in the urine in 24 hours. About 50% of the absorbed dose is metabolized
in the liver. Severe adverse side effects are infrequent, and well tolerated in most patients.
Sedation and dry mouth are the most common side effects, and are usually related to dose and
length of administration. [12, 13]
Figure 1. Structural formula of clonidine
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5. Mechanisms of action of spinal clonidine
It has been shown that epidural and spinal administration of clonidine in surgical patients
enhances quality and duration of neuroaxial anaesthesia, reduces dose of local anaesthetics as
well as others neuroaxial additives such opioids. It also produces a short period of postoper‐
ative analgesia, and lowers the dose of systemic postoperative analgesics.
G-protein-coupled receptors (GPCRs) are the largest and most diverse superfamily of mem‐
brane receptors responsible for signaling between cells and tissues, mediating most cellular
responses to hormones and neurotransmitters, playing important physiological roles in
homeostasis. They are a major drug targets. The alpha2 adrenoceptors are membrane proteins
belonging to these superfamily GPCRs, that form a group of 3 to 4 gene polymorphic products,
that mediate major central nervous system actions of norepinephrine and epinephrine,
including control of mood state, arousal, endocrine function, autonomic and somatic motor
outflows, and modulation sensory inputs, including pain. The alpha2 adrenoceptors are
located presynaptically and regulates the release of the neurotransmitter; they are also present
in postsynaptical locations.
Three distinct subtypes have been described, characterized and cloned; alpha2A, alpha2B, and
alpha2C. [14, 15, 16, 17] There is a fourth receptor called alfa2D that has been described and
their functions are still not known, although it appears that this receptor alfa2D is in fact, an
alpha2A-D subtype; the alpha2A in humans and the alpha2D in rats. [18]
Figure 2. Alpha2 adrenoceptors are membrane proteins belonging to the super family GPCRs. There are four sub‐
types. Their stimulation has wide therapeutic effects.
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The anatomic site of action of the alpha2 agonists involves specific receptors of the spinal dorsal
horn and supraspinaly in the nucleus coereleus in the pons. [19, 20, 21, 22] While the mecha‐
nism and location of action of the sedative effect of these compounds are due to the hyperpo‐
larization of excitable neurons localized in the nucleous coereleus, the analgesic effect of these
drugs is not completely understood, and have a complex mechanism. Alpha 2 agonists induce
analgesia by acting in different places; brain, brain stem, spinal cord and peripheral nerves.
Their supraspinaly analgesic mechanism in the locus coereleus is probably by transduction,
while in the spinal cord is likely related to activation of the descending medullospinal
noradrenergic pathways or to the reduction of spinal sympathetic outflow at presynaptic
ganglionic sites. Clonidine suppresses the generation of action potentials in tonic-firing spinal
dorsal horn neurons. This may be explained, in part, by an interaction with voltage-gated Na
+and K+currents.
Clonidine also acts synergistically with local anaesthetics because of its action of opening
potassium channels.
6. Spinal interactions between alfa2 agonists and opioids
It is an uncommon clinical practice to combine alpha2 agonists and opioids in spinal anaes‐
thesia to either enhance local anaesthetic effects or to provide postoperative analgesia. This
technique is based on the spinal synergism between these two drugs. When morphine and
clonidine are co-administered intrathecally, the resulting antinociception is greater than
expected if the drug responses were additive; thus, a synergistic interaction is present. [23,
24] For the most part, the underlying molecular synergy mechanisms are not known, although
some studies have identified both the delta and the mu-opioid receptors as candidate receptors
capable of interacting synergistically with alpha 2A agonists. Roerig et al [25] found in rats
that interactions between opioid and adrenergic agonists in mouse spinal cord were mediated
by delta and alpha2 receptor subtypes, the synergistic interaction between morphine and
alpha2 adrenergic agonists may involve action at delta opioid receptors, and antagonist action
on these drug interactions is intrincated. Stone and coworkers, [26] in a genetically modified
mouse line expressing a point mutation (D79N) in the alpha2A adrenergic receptor investi‐
gated the role of the alpha2A receptor in alpha2 agonist-evoked analgesia and adrenergic-
opioid synergy. They were able to demonstrate that the alpha2A subtype receptor is the
primary mediator of alpha2 adrenergic spinal analgesia and is necessary for analgesic synergy
with opioids, and concluded that combination therapies targeting the alpha2A receptor and
opioid receptors may be useful in maximizing the analgesic efficacy of opioids while decreas‐
ing total dose requirements. Although others have found that the alpha2C adrenergic receptor
subtype contributes to this synergy, [27] Chabot-Doré and coworkers [28] confirmed that
although other opioid receptors can interact synergistically with alpha2 receptors agonists,
Delta opioid receptor is sufficient for spinal opioid-adrenergic interactions. Protein kinase is
needed for this analgesic synergy. [29]
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Analgesic synergy between opioid and alpha2 adrenergic agonists is potentially beneficial by
increasing efficacy and/or reducing the total drug required to produce sufficient pain relief,
and undesired side effects can be minimized.
7. Safety of spinal clonidine
Neurotoxicity has not been reported following the use of intrathecal clonidine and generally
the drug is considered to be safe in this regard. Although subarachnoid administration of
clonidine has not been approved by the FDA or any other regulatory agency in the world, there
are experimental studies that have demonstrated its safety and efficacy when used by this
route. Continuous administration of spinal clonidine in Wistar rats during 14 days failed to
demonstrate neurotoxic damage. [30] Erddivanli and coworkers injected male Sprague-
Dawley rats [31] with 3 µg and 10 µg of intrathecal dexmedetomidine added to bupivacaine;
they found no apparent pathohistological changes 24 hours after a single injection. In male
Kunming mice 1 to 3 µg of dexmedetomidine displayed a robust analgesia via a alpha2-
receptor in a dose dependent manner and no significant pathological impacts on the spinal
cord were noticed, with a potential protective effects of lidocaine induced neural cell damage.
[32] In postnatal rats spinal clonidine produces age and dose-dependent analgesia, without
signs of spinal cord toxicity, even at doses bigger than required for analgesia. [33]
8. Clinical use of spinal clonidine
To enhance spinal anaesthesia and postoperative pain control clonidine can be injected in the
subarachnoid space as an adjuvant drug to opioids or local anaesthetics. A systematic review
by Elia et al [34] including 1, 445 patients using a wide variety of spinal clonidine doses as
adjuvant to subarachnoid bupivacaine, mepivacaine, prilocaine, or tetracaine found that 15 to
150 µg prolonged in a linear, dose-dependent manner, the time to 2 segment regression (range
of means, 14 to 75 minutes) and also delayed the regression time to L2 dermatome (range of
means, 11 to 128 minutes). The time to first analgesic request (median 101 minutes, range 35
to 310] and motor block (median 47 minutes, range 6 to 131] was extended with no relation to
dose. There were fewer episodes of intraoperative pain with clonidine (relative risk, 0.24; 95%
confidence interval [CI], 0.09-0.64; number needed to treat, 13] but more episodes of arterial
hypotension (relative risk, 1.81; 95% CI 1.44-2.28; number needed to harm, 8] without evidence
of dose-responsiveness. The risk of bradycardia was unchanged.
Side effects of intrathecal clonidine include sedation, hypotension and a reduction of the heart
rate. Especially in post-surgical patients these circumstance warrants specific attention.
The following paragraphs discuss spinal clonidine use in different anaesthetic and surgical
scenarios, as well as in the management of postoperative and labour pain.
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9. Ambulatory settings
Spinal anaesthesia side effects are a major concern in some patients and physicians and may
be reluctant to use this technique in ambulatory surgery. [35] Nowadays there are many articles
showing that spinal anaesthesia is a safe and effective technique in this clinical scenario. There
is an special interest to use adjuncts drugs such clonidine in order to decrease local anaesthetic
dose to promptly achieve a recovery profile. [36]
Several investigations in patients undergoing knee arthroscopy have shown that low doses of
clonidine [15 up to 45 µg) added to low doses of intrathecal hyperbaric bupivacaine [5-6 mg)
improves the quality of anaesthesia, prolong the motor block, without affecting time to home
discharge in outpatients. [37] In 60 ambulatory patients undergoing knee arthroscopy Marri‐
virta et al [38] added 75 µg clonidine to 6 mg spinal hyperbaric bupivacaine vs. 6 mg bupiva‐
caine alone. These researchers found that motor block was prolonged in those patients who
received clonidine without affecting home-readiness. Also these patients needed more
vasopressors and had less postoperative pain. Adding clonidine 15 µg to 8 mg of isobaric spinal
ropivacaine [39] did not prolonged motor or sensory blockade, but enhanced anaesthesia
quality for knee arthroscopy. Bigger doses such 75 µg produced significantly longer sensory
and motor blockade [195 ± 40 min and 164 ± 38 min; p < 0.05], but associated with sedation and
hypotension.
In our practice we have good results with doses of 45-150 µg. These doses of spinal clonidine
favor the reduction of local anaesthetics doses and do not prolong the recovery time of our
outpatients.
10. General surgery and urologic procedures
Numerous surgical procedures of the abdominal wall, abdominopelvic cavity, and retroperi‐
toneum can be performed under single injection of local anaesthetics in the spinal space. For
prolonged cases the use of adjuvant drugs improves the quality and increases the duration of
the subarachnoid block. Clonidine has been used successfully in various surgical procedures
of the abdomen and pelvis. Intrathecal clonidine 15, 30, 45 and 75 µg alone, or added to opioids
expand spinal anaesthesia sensory block and duration of motor block, and also provided
prolonged postoperative analgesia. In a randomized study [40] of 73 patients ASA physical
status I and II undergoing gynecological abdominal surgery with spinal bupivacaine 15 mg,
the authors compared clonidine 30 µg, sufentanyl 10 µg, clonidine 15µg plus sufentanil 15 µg
versus a control group. Sensory block to pinprick at 10 min was higher for clonidine and
sufentanil/clonidine groups compared to the control group (p < 0.02]. Anaesthetic time
(Bromage score 2] was also longer for clonidine and sufentanil/clonidine groups compared to
the control and sufentanil groups (p < 0.05]. Time to first rescue analgesics was shorter in the
control group compared to the other groups (p < 0.02]. The dose of intramuscular diclofenac
in 24 hours was higher in the control group compared to all other groups (p < 0.05]. The
incidence of adverse effects and ephedrine consumption were similar among groups. Cloni‐
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dine 75 µg associated with 17.5 mg hyperbaric bupivacaine 0.5% for lower abdominal surgeries
[41] with high level spinal anaesthesia (T4] induced a higher incidence of arterial hypotension
but prolongs sensory block and postoperative analgesia similar to clonidine 45 µg. In lower
abdomen surgeries, Yoganarasimha and coworkers [42] compared intrathecal clonidine 75 µg
versus intrathecal neostigmine 50 µg as adjuvant drugs for spinal anaesthesia 0.5% hyperbaric
bupivacaine 12.5 mg; analgesia was prolonged significantly with clonidine [362 ± 36 min)
compared with neostigmine [300 ± 25 min)(p < 0.05]. No serious adverse effects were noted
perioperatively in either group. In an interesting clinical study with 60 patients undergoing
right colon resection under general anaesthesia, preoperative intrathecal clonidine was
superior to bupivacaine to prevent postoperative secondary hyperalgesia; [43] the authors
compared the effect of clonidine 300 µg versus bupivacaine 10 mg intrathecally versus saline
(control group): morphine needs patient controlled postoperative analgesia were less in the
clonidine group [31.5±12 versus 91±25.5 and 43±15 mg, respectively, in groups clonidine,
saline, and bupivacaine: p < 0.05 at 72 postoperative hours). The area of mechanical hyperal‐
gesia at 72 h was 3±5 cm2 in the clonidine group versus 90±30 and 35±20 cm2 in the saline and
bupivacaine groups (p < 0.05]. After 6 months, fewer patients in the clonidine group experi‐
enced residual pain than in the saline group [0 of 20 versus 6 of 20, p < 0.05]. In laparoscopic
procedures done under bupivacaine spinal anaesthesia, clonidine 30 µg produced good
sedation, intra and postoperative analgesia, and abolished shoulder tip pain during the
procedures. [44] For inguinal hernioplasthy [45, 46] adding clonidine 15 or 30 µg to small doses
of hyperbaric bupivacaine enhance spinal anaesthesia, prolongs the time to first analgesic
request, and decreases postoperative pain, compared with bupivacaine alone. Thirty µg
clonidine was associated with higher incidence and duration of hypotension than 15 µg of
clonidine.
Some research has shown the usefulness of intrathecal clonidine in urology procedures,
although there are some controversies. In a controlled, prospective, double-blind investigation
with patients undergoing elective transurethral resection of bladder tumours under spinal
anaesthesia [47] the authors found that adding clonidine 75 µg to prilocaine 75 mg increased
the duration of sensory and motor block and reduced the need for additional postoperative
analgesics by providing excellent analgesia for about 8 hours during recovery period. In a
similar study, 25 µg spinal clonidine improved bupivacaine spinal anaesthesia: shorter time
to achieve complete motor block and sensory block at T9 level, with longer postoperative
analgesia. [48] In 60 patients undergoing transurethral resection of prostate or bladder tumors
Kanazi et al [49] compared clonidine 30 µg, versus dexmedetomidine 3 µg added to 12 mg
spinal hyperbaric bupivacaine, versus bupivacaine alone. Patients treated with alpha2 agonists
had a significantly shorter onset time of motor block and significantly longer sensory and
motor regression times than patients who only received local anaesthetic. The mean time of
sensory regression to the S1 segment was 303 ±75 min for those injected with dexmedetomi‐
dine, 272 ±38 min in the group who received clonidine and 190±48 min in patients with
bupivacaine alone (bupivacaine versus dexmedetomidine and bupivacaine versus clonidine,
p< 0.001]. The regression of motor block to Bromage 0 was 250 ±76 min, 216±35 min, and 163±47
min respectively (bupivacaine versus dexmedetomidine and bupivacaine versus clonidine, p<
0.001]. The onset and regression times were not significantly different between patients treated
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with the alpha2 agonists. The mean arterial pressure, heart rate and level of sedation were
similar in the three groups intra-operatively and post-operatively. Andrieu and his group [50]
compared intrathecal morphine 4µg/kg without or with clonidine 4µg/kg, or PCA in patients
undergoing radical retropubic prostatectomy under general anaesthesia with sevorane-N2O.
Adding clonidine to spinal morphine reduced intraoperative use of sufentanil, prolonged time
until first request for PCA rescue, and added prolonged analgesia at rest and during coughing.
In contrast with previous mentioned studies, Larsen et al [51] compared 75 µg versus 150 µg
of clonidine added to 80 mg mepivacaine 4%, versus spinal mepivacaine alone in patients who
had transurethral surgery and found that clonidine had no effect on the onset time, spread or
intensity of subarachnoid anaesthesia. The higher dose prolonged the duration of sensory
block by 50 minutes and the duration of motor block by 40 minutes, while 75 µg had no
significant effect. Heart rate and mean arterial pressure were significantly reduced in both
clonidine groups when compared to plain mepivacaine. There was no significant reduction in
postoperative analgesic demand. They do not recommend the routine addition of clonidine
for spinal anaesthesia with local anaesthetics. There is a reported case of late respiratory
depression (16 h after spinal block) in a 70 year old man undergoing prostatic adenomectomy
done under spinal anaesthesia with 10 mg bupivacaine, 30 µg clonidine and 100 µg morphine.
Intrathecal mixture of morphine-clonidine in older patients must be careful monitored. [52]
10.1. Orthopaedic
Postoperative pain following orthopaedic surgeries has been shown to be a significant negative
factor that delay patient recovery and contributes to serious complications. It may also result
in larger use of healthcare resources and ultimately lead to poor outcomes. The utilization of
multimodal pain management following large orthopaedic surgeries like total joint arthro‐
plasty, total knee replacement, or spinal surgery has positively affected the quality of postop‐
erative care, reduced surgical pain, and decreased the magnitude of opioid consumption and
subsequent dose-related complications. Multimodal spinal anaesthesia-analgesia including
spinal clonidine is safe and may reduce hospital stay, decrease postoperative complications,
and increase patient satisfaction.
In a dose-response prospective study, Strebel et al [53] compared three doses of clonidine (37.5,
75 and 150 µg) added to spinal 0.5% bupivacaine 18 mg in 80 orthopaedics patients. Duration
of sensory block (regression below level L1) was increased in patients receiving intrathecal
clonidine: 311±101 min in 37.5 µg (+8%), 325 ±69 min in 75 µg (+13%), and 337±78 min in those
patients who received 150 µg (+17%) (estimated parameter for dose 0.23 [95% confidence
interval-0.05-0.50]). versus control group 288 ±62 min. Time to first analgesic request was also
prolonged: 343 ±75 min (+16%), 381±117 min (+29%), and 445±136 min (+51%) (estimated
parameter for dose 1.02 [95% confidence interval 0.59-1.45]), respectively compared to control
group 295±80 min. Hemodynamic stability was maintained and they found no differences in
sedation level. van Tuijl and coworkers [37] investigated the effect of 0, 15 and 30 µg of
clonidine added to 5 mg hyperbaric bupivacaine on the duration of motor block, analgesia and
ability to void after knee arthroscopy. They found that clonidine increased motor block
duration by 25 and 34 min respectively. They also found better analgesic quality, and the mean
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time for spontaneous voiding was increased up to 18 and 44 min respectively. Amaranto and
Berrío demonstrated that spinal clonidine 2 µg/kg added to hyperbaric lidocaine in orthopae‐
dic cases enhance anaesthesia quality, significantly prolonged post operative analgesia, with
early motor recovery and minimal side effects. [54] In adolescents scheduled for lower
extremities orthopaedic surgery under spinal anaesthesia with isobaric 0.5% bupivacaine
added with clonidine 1 µg/kg prolonged duration of sensory and motor block, produced
extended spinal postoperative analgesia by 120 min, without severe side effects. [55] Spinal
sufentanil 75 µg alone, or added with epinephrine 200 µg, or clonidine 30 µg after total hip
replacement results in good analgesia with similar onset and duration of action, and minor
side effects. [56] Compared with intrathecal dexmedetomidine, clonidine had a similar results
in patients undergoing lower limb surgery with spinal bupivacaine; Mahendru et al [57]
conducted a prospective study adding clonidine 30 µg, vs. dexmedetomidine 5 µg, vs. fentanyl
25 µg to 12.5 mg spinal hyperbaric bupivacaine in cases of lower limb surgeries. They discov‐
ered that dexmedetomidine prolonged significantly sensory and motor block compared to
clonidine, fentanyl and bupivacaine alone. The mean time of two segment sensory block
regression was 147±21 min with dexmedetomidine, 117±22 with clonidine, 119±23 in those
patients receiving fentanyl, and 102±17 in bupivacaine alone (p> 0.0001). The regression time
of motor block to reach modified Bromage 0 was 275±25, 199±26, 196±27, 161±20 respectively
(p > 0.0001). Hemodynamic stability was conserved. In patients 60 years or older undergoing
lower extremity orthopaedic surgeries, intrathecally clonidine 15 µg or 30 µg with 9 mg
hyperbaric bupivacaine, significantly potentiated the sensory block levels and duration of
analgesia without affecting the trend of systolic blood pressure as compared to bupivacaine
alone. Clonidine in doses of 30 µg however facilitated the ascent of sensory level block to
unexpectedly higher dermatomes for a longer time. [58] Spinal postoperative analgesia can be
improved by epidural infusion of 40 µg/h-1 mixed with ropivacaine 4 mg/h-1 in patients
undergoing hip arthroplasty. [59]
Some studies have found conflicting data which showed that spinal clonidine is not a useful
adjuvant for postoperative analgesia in orthopedic major surgery. Gehling et al [60] evaluated
45 patients undergoing hip or knee replacement under 15 mg bupivacaine spinal anaesthesia
and found a mean time until first opioid request was for placebo 10.3±7.9 h, for 0.1 mg
morphine 23.0±3.9 h and for 0.1 mg morphine+50 µg clonidine 21±6.9 h, respectively. Co-
administration of pethidine 0.75 mg/kg-1 and clonidine 75 µg provided good intraoperative
anaesthesia for total hip replacement, but similar to plain isobaric 0.5% bupivacaine. [61]
11. Obstetrics
The role of the anesthesiologist in obstetrics has many responsibilities; labour analgesia,
anesthesia for vaginal delivery, anaesthesia for cesarean section, anaesthesia for non-obstetric
surgeries during pregnancy, and postoperative analgesia. A comprehensive labour analgesia
program has to include newer procedures and ajuvant drugs to facilitate ambulation, excellent
pain relief, patient comfort and safety for the mother-fetus binomial. [62, 63, 64] Spinal
clonidine has been used for labour analgesia, to enhance spinal anaesthesia during cesarean
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section, and for postoperative pain relief. Its use tends to be more frequent in this field, since
it reduces opioids doses, and thus the side effects such as emesis and maternal pruritus, and
the possibility of respiratory depression secondary to rostral opioid distribution. Theoretically,
it could also reduce the fetal bradycardia.
Labour analgesia. There are many advances in the pharmacology of labour analgesia focused
on alternatives mechanisms to target spinal pain receptors, and the efficacy and safety of old
and new drugs and techniques; i.v. remifentanyl for patient controlled analgesia, low dose of
diluted local anaesthetics, addition of neuraxial adjuvants like opioids, neostigmine, and
clonidine. [65, 66, 67, 68]
Most studied doses of intrathecal clonidine for labour analgesia range from 15 to 45 µg mixed
with opioids and/or local anaesthetics. In a preliminary open-label protocol done in France by
Mercier and coworkers [69] comparing sufentanil 5 µg+clonidine 30 µg versus sufentanil 5 µg
alone injected intrathecally to alleviate pain during the first stage of labour, the authors
demonstrated that clonidine potentiate labour analgesia and side effects such hypotension,
maternal pruritus and sedation were similar in both groups. In a second research, the same
group [70] studied 53 nulliparous women in painful labour using the same doses, but followed
by 5 mg of epidural bupivacaine. In this study the duration of analgesia was longer in the
sufentanil-clonidine group versus sufentanil alone [125±46 versus 97±30 min, p=0.007]. There
were more incidents of hypotension and ephedrine needs in those patients who received
sufentanil and clonidine. The incidence of fetal heart rate abnormalities during the first 30 min
after spinal injection was similar in both groups [17% versus 19%). No parturient had motor
blockade. Gautier et al [71] found that 30 µg of intrathecal clonidine plus 2.5 or 5 µg intrathecal
sufentanil increased the duration of labour analgesia during the first stage without undesirable
maternal or fetal effects. Labbene et al. [72] added clonidine 15 µg to 2.5 mg isobaric bupiva‐
caine and 5 µg sufentanil during combined spinal-epidural analgesia resulting in extended
duration of analgesia without increasing side effects. In nonobstetrical patient doses of 25 to
30 µg of clonidine augmented duration of postoperative analgesia, so smaller dose of clonidine
may be effective in the obstetric population.
Chiari et al from Austria [73] did the first study using spinal clonidine as a sole drug for labour
analgesia; in 36 parturients with < 6 cm cervical dilation; they compared 50, 100, and 200 µg
intrathecal clonidine and found that labour pain was significantly reduced in all patients,
analgesia duration was significantly longer with 200 µg (median 143; range 75-210 min), with
100 µg (median 118; range 60-180 min) and using 50 µg (median 45; range 25-150 min).
Hypotension was associated with 200 µg and the need of intravenous ephedrine more often
than in the other groups.
There are controversies in the use of spinal clonidine for labour analgesia as some researchers
have found a higher frequency of maternal hypotension, foetal arrhythmia, and worse neonatal
umbilical artery pH. Therefore, some of them do not recommend its use. [74, 75, 76] The study
done by Paech et al [77] with subarachnoid fentanyl 20 µg+bupivacaine 2.5 mg, plus either
saline or clonidine 15, 30 or 45 µg found that addition of clonidine to fentanyl-bupivacaine
reduced maternal blood pressure and did not significantly augment the duration of spinal
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labour analgesia. To avoid hypotension due to the combination of spinal clonidine-opioids-
diluted local anaesthetics, epidural clonidine can be used in doses of 75 µg. [78]
When low doses of clonidine with or without opioids are used for spinal labour analgesia, we
must remember that at the end of pregnancy there is a degree of autoanalgesia mediated by
endorphins [79] Even though neuraxial analgesia is the most efficient and safest mode of labour
analgesia, the use of spinal clonidine mixed with opioids and/or local anaesthetics must be
used cautiously to avoid hypotension.
Cesarean section. Nowadays, spinal anaesthesia is the most used technique for cesarean section.
[80] Currently, opioids are the drugs most commonly used as adjuvants in this clinical scenario,
but its side effects are troubling. Low doses of spinal clonidine in cesarean section are used to
improve the anaesthetic block, to reduce the dose of local anaesthetics, and to prolong
postoperative analgesia. It can also be combined with intrathecal opioids, as there is a synergic
effect as discussed in previous paragraph.
In a recent study, 37.5 µg of clonidine added to hyperbaric bupivacaine was suggested as the
optimal dose for emergency cesarean surgery, allowing reduction of up to 18% of the total
dose of hyperbaric bupivacaine. [81] Adding clonidine 75µg to hyperbaric bupivacaine
prolongs spinal anaesthesia and improves early postoperative analgesia after cesarean section,
but does not diminish morphine needs during the first 24 hours of the postoperative period.
[82] Other studies have found that 75 µg is a safe dose; prolong the anaesthetic block and
enhance postoperative analgesia, with minimal side effects and no harm to the newborn. [83,
84, 85] In a randomized, double blind, dose finding study, Peach et al [86] compared intrathecal
clonidine mixed with fentanyl and morphine versus clonidine plus morphine in 240 women
undergoing cesarean section with hyperbaric 0.5% bupivacaine. A dose-finding analysis
showed similar postoperative efficacy and side effects for groups receiving morphine 100µg
with clonidine 60, 90, or 150 µg and concluded that a multimodal approach to postcesarean
analgesia, using subarachnoid bupivacaine, fentanyl, morphine 100 µg, and clonidine 60 µg,
improves pain relief compared with morphine 100 µg or clonidine 150 µg alone, but increases
intraoperative sedation and may increase perioperative vomiting. In another dose finding
study [87] comparing 15 µg, 30 µg and 60 µg of clonidine added to hyperbaric bupivacaine
0.5%, the authors found a dose dependent variability of analgesia duration and sedation.
Duration of analgesia was significantly higher in those patients who received clonidine 60 µg
as compared to the other two groups (598.7±140.47 versus 436.65±149.84 and 387.1±97.05
minutes respectively). Sedation was also more in the highest dose. In this study the authors
recommended 15 µg and 30 µg doses due to good postoperative analgesia and less sedation.
As a single drug, subarachnoid clonidine is not recommended neither for anaesthesia or post
cesarean analgesia. In order to evaluate the analgesic effect of clonidine, a double blind study
was carried out in 20 patients undergoing elective cesarean section; [88] 150 µg of spinal
clonidine were injected 45 min after general anaesthesia and compared to intrathecal saline as
control group. Pain intensity was lower in clonidine treated patients from 20 to 120 min after
intrathecal injection (p< 0.05), request for first analgesic was also longer in the clonidine group
414±128 min versus 181±169 min (p< 0.01). Clonidine side effects were severe; hypotension
with a maximal reduction of systolic (15±9%), diastolic (22±12%) and mean arterial pressure
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(18±12%). Sedation was significantly more intense compared to saline (p<0.05), also dried
mouth was more commonly (p<0.01). Although these data suggest that 150 µg subarachnoid
clonidine is effective to treat acute pain after cesarean section, it has side effects such as
hypotension, sedation, and dryness of mouth.
In a research [4] using 150, 350 and 450 µg of spinal clonidine performed to evaluate the dose-
response hemodynamic and analgesic profiles in the immediate postoperative period of
cesarean section under general anaesthesia. The authors found that pain was less in all groups
in a dose dependent mode: request for first analgesic 402±75 min, 570±76 min, and 864± 80 min
respectively (p<0.01-0.001]. Clonidine reduced mean arterial pressure compared with baseline
only in those patients treated with 150 µg (21±13%, p < 0.05). Sedation was evident in all groups.
Respiratory rate and motor activity of the lower extremities were unaffected in all three groups.
The hemodynamic stabilility after 300 and 450 µg suggested a pressor consequence at periph‐
eral sites. In an unpublished research we found that 75 µg of spinal clonidine was not enough
to perform curettage in patients with incomplete abortion.
12. Pediatrics
Spinal anaesthesia is safe and effective in children, with many advantages like minimal cardio-
respiratory disturbances. Its major limitation is its short duration, which can be extended, as
in adults, with the mixture of adjuvants drugs. [90, 91] In postnatal rats, spinal clonidine did
not produce signs of neurotoxicity, [33] and has been used in all pediatric age groups, from
newborns to teenagers. In newborns, Rochette and coworkers [92] studied 75 patients which
were injected with increasing doses of clonidine (0.25, 0.5, 1 y 2 µg/kg) with plain spinal
bupivacaine 0.5% (1 mg/kg) and concluded that clonidine 1 µg/kg produces improvement in
spinal anaesthesia duration without significant side effects. Dose of 2 µg/kg produced transient
hypotension. In a randomized investigation with 45 children aged 6 to 15 years, clonidine 2
µg/kg prolonged motor block and improved postoperative analgesia. Hypotension and
bradycardia were 54% and 30% respectively. [93] In children aged 6-8 year undergoing spinal
anaesthesia with 0.5% bupivacaine for orthopedic surgery, the addition of clonidine 1 µg/kg
prolonged significantly the time to regression of the sensory block and recovery of motor block,
also delayed time for first rescue analgesia. Sedation was augmented and propofol require‐
ment were reduced. [94] Batra et al [95] also demonstrated that intratecal clonidine 1 µg/kg
reduces propofol dose for sedation in children.
13. Postoperative pain
The term balanced spinal analgesia refers to the antinociceptive effect produced by the
interaction between several drugs that injected inside the subarachnoid space would abolish
or reduce the intensity of postoperative pain. Spinal non opioids adjuvants compounds have
moderate to low analgesic potency, but combined with opioids allow a decrease of opioids
Intrathecal Clonidine as Spinal Anaesthesia Adjuvant — Is there a Magical Dose?
http://dx.doi.org/10.5772/58712
109
dose for postoperative pain control, resulting in less opioids side effects, promoting recovery
and faster home readiness. Spinal alpha2 agonist drugs are not used routinely as a single
analgesic in the postoperative period. A single dose of spinal clonidine as a sole postoperative
analgesic has poor effect. When clonidine is added to spinal local anaesthetics or spinal opioids
it does extend the time to first analgesic dose and decrease the total amount of systemic
postoperative opioids. Clonidine spinal synergism with other analgesics is due to antinoci‐
ceptive actions that have been described in previous paragraphs. In previous sections we have
discussed some aspects of postoperative analgesia produced by intrathecal clonidine in
various surgical scenarios. In this section we discuss more details on the prevention of
postoperative pain with spinal clonidine.
Adding clonidine 150 µg to spinal bupivacaine in patients undergoing femoral osteosynthesis
prolonged significantly the first request for analgesics compared to oral clonidine and plain
spinal bupivacaine (337±29 min, 313±29 versus 236±27 min respectively), and reduced the total
dose of morphine. [96] Combining 50 mg of hyperbaric lidocaine, 25 µg fentanyl, and clonidine
150 µg produced excellent postoperative analgesia in proctological patients. [97] Small doses
of spinal clonidine also produce postoperative analgesia without deleterious side effects. In a
comparative evaluation of 15 µg versus 30 µg clonidine as analgesic adjuvant added to 15 mg
of spinal 0.5% hyperbaric bupivacaine in 90 patients undergoing abdominal hysterectomy, the
authors [98] found a prolonged first pain complaint time for those women treated with
clonidine compared with patients who did not received spinal clonidine (315.37+50.3,
387.07+83.19 versus 204.8+34.8 minutes). Hemodynamic parameters were alike in all patients.
A recent meta-analysis by Engelman and Marsala [99] found that clonidine increased the
duration of postoperative analgesia by 1.63 h [95% confidence interval (CI): 0.93-2.33]. There
was a 90% probability that clonidine increases the duration of postoperative analgesia by more
than 75 min compared with morphine alone. They also found that spinal clonidine decrease
the need for postoperative morphine by a mean of 4.45 mg. (95% CI: 1.40-7.49 mg). Hypoten‐
sion was the only side effect increased by clonidine (odds ratio 1.78; 95% CI: 1.02-3.12). In
patients undergoing transurethral surgery, 25 µg clonidine plus 7.5 mg of subarachnoid
isobaric bupivacaine significantly delayed time for first request supplemental analgesia
compared to bupivacaine alone (434.1±78. 3 min versus 263.97±40.38 min p=0.000) respectively.
[48] In a recent study done with clonidine 30 µg added to intratecal bupivacaine-fentanyl, the
authors demonstrated that the incidence of intraoperative pain and postoperative analgesic
requirements were significantly less compared with the patient who did not received the alfa2
agonist for vaginal hysterectomy. [100]
Chest pain after coronary artery bypass surgery has been relieved with intrathecal clonidine
in doses 1 µg/kg or 100 µg, with or without spinal opioids. Adding clonidine to neuraxial
opioids improves the quality of analgesia postoperatively and expedites the process of
weaning from mechanical ventilation, allowing earlier extubation. No serious side effects have
been described. [101, 102, 103]
Baker and coworkers [104] hypothesized that hyperbaric clonidine avoid its rostral migration,
and consequently reduced some of its side effects such as hypotension, bradycardia and
sedation. They use 150 µg of either isobaric or hyperbaric clonidine in 30 elderly patients found
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that patients in the first group needed more intravenous fluid administration, have more
bradycardia, but duration of analgesia was significantly larger than in the hyperbaric clonidine
group (median, 400 min; range, 115-400 min versus median 265 min; range, 205-400 min. p <
0.05). Sedation scores did not differ between groups.
In conclusion, for postoperative pain the addition of clonidine to intrathecal local anaesthetics
and/or opioids extends the time to first analgesia and decreases the amount of opioids used.
Severe hypotension and bradycardia are seldom observed, and sedation is not an important
side effect.
14. Controversy over spinal clonidine dose
As reviewed, there is no universal agreement on recommended dose for the various clinical
uses of spinal clonidine. Recently, Ginosar, Riley and Angst [105] did a nice study in volunteers
and found out a clonidine dose dependant effect. Significant analgesia to experimental heat
pain was detected above 25 µg. After 50 µg the heat pain tolerance increased by that ∼1°C,
similar to the analgesic effect of 5 mg epidural morphine or 30 µg epidural fentanyl observed
in studies using this experimental heat pain model.
Table 1 shows the different doses of intrathecal clonidine in different clinical scenarios of
subarachnoid anaesthesia and analgesia. It can be seen that the dose range is wide as already
discussed in this chapter. Up until today, there is not a standard recommended dose of
subarachnoid clonidine. Doses range from 15 up to 450µg. It is necessary to adjust the dose to
several factors: age, type of patients, time of surgery, type of surgery and dose of local
anaesthetic and intrathecal opioids used.
Type of surgery Dose range µg Effects Reported side effects References
Ambulatory 15 to 150 Enhance anaesthesia quality Prolongs motor block [37, 38, 39]
Postoperative analgesia Hypotension
General surgery 15 to 75 Enhance sensory and motor block Hypotension [41, 42, 43,





hyperalgesia and chronic pain
Decreases postoperative analgesic
consumption
Urology 25 to 150 Shortens latency time Bradycardia [47, 48, 49,
50, 51]4 µg/kg Retrace regression 2 segments/S1
segment
Hypotension
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Type of surgery Dose range µg Effects Reported side effects References
Longer postoperative analgesia
Reduce intraoperative opioids
Orthopaedics 15 to 150 Increases regression to L1
segment and motor block
duration
Facilitates high spinal block [37, 53, 54,
55, 56, 57, 58,
60, 61]
1-2 µg/kg
Enhance quality anaesthesia Prolongs time to void
Prolongs time for first analgesic
Obstetrics
Labour analgesia 15 to 45 Potentiates opioid spinal
analgesia
Maternal hypotension [69, 70, 71,
72, 73, 74, 75,
76]50 to 200* Reduce labour pain Maternal dry mouth
Fetal arrhythmias
Prolongs analgesia Fetal acidosis
Cesarean 37.5 to 450 Enhance anaesthesia Maternal hypotension [81, 82, 83,
84, 85, 86, 87,
88]
Postoperative analgesia Sedation
Prolongs time for first analgesic
request
Pediatrics 1 to 2 ** Prolongs spinal blockage Sedation *** [92, 93, 94,




30 to 450 Enhance spinal anaesthesia Sedation [48, 96, 97,
98, 99, 100,
102, 103]




in a dose response manner




* Sole analgesic, ** µg/kg, *** Only with 2 µg/kg
Table 1. Use of spinal clonidine
15. Conclusions
Spinal anaesthesia was described over 100 years ago. Since then, neuroaxial drug administra‐
tion has advanced exponentially and nowadays includes a large variety of medication that
provides not only anaesthesia, but analgesia as well. The growing interest in alpha2 agonists
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for intrathecal use has motivated innumerable research due to its ability to improve anaes‐
thesia and neuraxial analgesia without the side effects of opioids such as respiratory depres‐
sion, pruritus and urinary retention. Their analgesic effect is due to their binding on alpha2
adrenoreceptors localized in the brainstem nuclei and spinal substantia gelatinosa linked to
analgesic mechanisms. A synergistic action between opioids and clonidine at the level of the
spinal cord has been suggested. Clonidine also acts synergistically with local anaesthetics
because of its action of opening potassium channels. Side effects of intrathecal clonidine
include sedation, hypotension and a reduction of the heart rate. Spinal clonidine doses from
15 up to 450 µg are used in diverse clinical scenarios as adjuvant drug to local anaesthetics
and/or opioids with the main goal to enhance spinal analgesia-anaesthesia. Clonidine and
dexmedetomidine side effects are sedation, dose related bradycardia and hypotension, but
rarely reach critical levels and are easy to treat. The largest evidence about the effectiveness of
intrathecal clonidine is provided by studies on post-surgical pain. Although intratecal
clonidine is safe, in obstetrics patients we still need to use the smallest dose based on current
recommendations.
This chapter may serve as a review to help clinicians decide whether or not to use spinal
clonidine as adjuvant drugs in their daily practice.
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